Increased levels of soluble endoglin (Sol-Eng) correlate with poor outcome in human cancer. We have previously shown that shedding of membrane endoglin, and concomitant release of Sol-Eng is a late event in chemical mouse skin carcinogenesis associated with the development of undifferentiated spindle cell carcinomas (SpCCs). In this report, we show that mouse skin SpCCs exhibit a high expression of hepatocyte growth factor (HGF) and an elevated ratio of its active tyrosine kinase receptor Met vs total Met levels. We have evaluated the effect of Sol-Eng in spindle carcinoma cells by transfection of a cDNA encoding most of the endoglin ectodomain or by using purified recombinant Sol-Eng. We found that Sol-Eng inhibited both mitogen-activated protein kinase (MAPK) activity and cell growth in vitro and in vivo. Sol-Eng also blocked MAPK activation by transforming growth factor-1 (TGF-1) and impaired both basal and HGF-induced activation of Met and downstream MAPK. Moreover, Sol-Eng strongly reduced basal and HGF-stimulated spindle cell migration and invasion. Both Sol-Eng and full-length endoglin were shown to interact with Met by coimmunoprecipitation experiments. However, full-length endoglin expressed at the plasma membrane of spindle carcinoma cells had no effect on Met signaling activity, and was unable to inhibit HGF-induced cell migration/invasion. These results point to a paradoxical suppressor role for Sol-Eng in carcinogenesis. 
Introduction
Many cell-surface membrane receptors are proteolitically cleaved at their juxtamembrane region in a process called "shedding", which results in the release of the ectodomain into the extracellular space. Shedding may downregulate receptors at the cell surface and generate soluble forms that either antagonize or favor the formation of active signaling complexes with ligands (1) . Endoglin (CD105) is a membrane glycoprotein that acts as a coreceptor for members of the transforming growth factor- (TGF-) superfamily, including TGF-1, TGF-3, activin-A, BMP2, BMP7, BMP9 and BMP10 (2) . Endoglin plays a crucial role in cardiovascular development and angiogenesis (3, 4) . Mutations in the endoglin gene are responsible for the hereditary hemorrhagic telangiectasia type 1 (HHT1), a vascular disorder characterized by epistaxis, cutaneous telangiectases and arteriovenous malformations in brain, lung and liver (5) . In cancer, endoglin has also emerged as an important modulator of malignant progression by influencing tumor cell proliferation, motility, invasion and metastasis (reviewed in refs. 2, 6) . Thus, endoglin behaves as a suppressor of malignancy in skin, esophageal, prostate and breast carcinomas (7) (8) (9) (10) , while promotes tumor growth and invasiveness in Ewing sarcoma and melanoma (11) .
A soluble endoglin form (Sol-Eng) resulting from the cleavage of full-length endoglin by the membrane-anchored matrix metalloprotease MMP14 has been detected in the circulation associated with different pathologies, including preeclampsia and cancer (12) (13) (14) . Preeclampsia is a specific syndrome of pregnancy characterized by hypertension and proteinuria, which is linked to elevated levels of Sol-Eng and placenta-derived soluble VEGF receptor 1 (also known as soluble fms-like tyrosine kinase-1, sFlt1) (15) . Sol-Eng inhibits angiogenesis (12, 14) and increases blood pressure and vascular permeability (13, 14) . Whereas it has been proposed that these effects are mediated by Sol-Eng trapping circulating TGF-1, thus impairing its binding to the functional receptors (14) , other authors have found that Sol-Eng binds directly and with high affinity BMP9 and BMP10, but not TGF-1 or TGF-3 (16, 17) . Sol-Eng has also been detected in the plasma, serum and urine of cancer patients. Interestingly, elevated levels of circulating Sol-Eng is a bad prognostic factor in breast, colorectal and prostate cancer that correlates with metastasis (18-21). We have shown that cleavage of membrane endoglin, and concomitant generation of Sol-Eng occurs during progression of chemical mouse skin carcinogenesis, which is associated with the development of highly malignant undifferentiated spindle cell carcinomas (SpCCs) (22). Though Hawinkels and coworkers suggested an anti-angiogenic role for Sol-Eng in the tumor microenvironment (12) , the function of Sol-Eng in carcinogenesis remains to be determined.
Hepatocyte growth factor (HGF) signaling through its membrane tyrosine kinase receptor Met plays an important role during embryonic development and tissue remodeling. Yet, HGF/Met aberrant signaling is also associated with cancer, since Met hyperactivation promotes different processes related to malignant progression, including tumor cell proliferation, migration, invasion, metastasis and angiogenesis (23, 24) .
In this work, we show that mouse spindle cell carcinomas generated by chemical carcinogenesis express elevated levels of HGF. Sol-Eng, but not membrane-bound fulllength endoglin, inhibited baseline and HGF stimulated Met signaling, impairing proliferation, migration and invasion of spindle carcinoma cells. These results suggest an anti-oncogenic role for Sol-Eng in carcinogenesis.
Materials and methods

Cell culture conditions and treatments
The origin and characteristics of the mouse epidermal cell lines used in this work are summarized in Supplementary Dulbecco's modified Eagle's medium (CarB, CarC, MSC11A5), in 10% fetal bovine serum and antibiotics (2.5 g/ml amphotericin B, 100 g/ml ampicillin, 32 g/ml gentamycin) (Gibco). Cultures were maintained on plastic at 37ºC in a 5% CO 2 -humidified atmosphere.
For TGF-1 and HGF treatments, recombinant human TGF-1 and HGF (PreproTech EC) were added to CarC cell transfectants growing in the absence of serum at the indicated concentrations. Treatments with recombinant human Sol-Eng (rhSolEng) were performed by pre-incubating cells with the indicated concentrations of rhSolEng (R&D Systems) for 1 h.
Plasmids and transfections
The HA-tagged human endoglin cDNA in pDisplay (27) was used to derive by PCR a truncated endoglin construct encoding a soluble form encompassing the orphan domain and the ZP-N domain (amino acids 26-437). The 1.3-kb PCR product was cloned into pCRII-TOPO (Invitrogen) and the endoglin fragment was inserted into the EcoRI site of the pCAGGS plasmid under the control of a ubiquitous actin promoter resulting in the pCAGGS-Sol-Eng vector (13) . The plasmid pSV2neo (Clontech) contains a neomycin resistance gene.
CarC cells were co-transfected with pCAGGS-Sol.Eng and pSV2neo vectors at a 10:1 ratio, as described (28) . Briefly, 10 g of plasmid DNA were mixed with 20 g of Lipofectamin (Life Technologies, Inc.) in serum-free medium according to the protocol provided by the manufacturer. Positive clones were selected in the presence of 400 g/ml of the antibiotic G418 and screened for the presence of soluble endoglin using a commercial ELISA kit (Quantikine Human Endoglin/CD105, R&D Systems). Two clones expressing/secreting substantial amounts of Sol-Eng (CSE1 and CSE3) were selected for further studies. Parallel transfections with pSV2neo alone yielded endoglinnegative mock transfectants. Pooled clones were used for biochemical and functional studies.
HEK-293T cells were transiently cotransfected with cDNAs encoding the fulllength wild-type human c-Met in pBABE puro vector (Addgene plasmid 17493; see ref.
29) and a cDNA encoding either the full-length human endoglin or its whole extracellular domain (amino acids 26-586, including the orphan domain and ZP-N and ZP-C domains), both tagged with HA, in pDisplay, as previously described (30) . Cells were lysed 24 h after transfection and protein expression was determined by Western blotting and coimmunoprecipitation experiments.
Stable transfection of the cDNA encoding the full-length human L-endoglin isoform subcloned into the pcDNA3 expression vector was carried out as previously 
Western blot and coimmunoprecipitation experiments
For detection of proteins in Western blots, cells were lysed at 4ºC in modified RIPA buffer and a cocktail of protease (2 g/ml aprotinin; 2 g /ml leupeptin; 1 mM phenylmethylsulfonil fluoride) and phosphatase (1 mM sodium orthovanadate; 2 mM -glycerophosphate; 0.2 mM sodium fluoride) inhibitors (Sigma-Aldrich). Proteins were separated by sodium dodecyl sulfate-polyacrilamide gel electrophoresis and then transferred to Immobilon-P membranes (Millipore). For immunodetection of proteins, the following antibodies were used: 12CA5 mAb (Roche Diagnostics) for HA-Sol-Eng; P4A4 mAb (Santa Cruz Biotechnology) for human full-length endoglin (7); the mAb 1D4 recognizing glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was purchased from Enzo Life Sciences AG; the Abs specific for p44/42 MAPK (ERK1/2) (#9102), phospho-p44/42 MAPK (Thr202/Tyr204) (#9101S), as well as a mAb specific for phospho-Met (Tyr1234/1235) (D26) (#3077), all were from Cell Signaling; a polyclonal Ab recognizing Met (sc-162) was from Santa Cruz Biotechnology Inc. Appropriate secondary Abs coupled to horseradish peroxidase were used. Peroxidase activity was developed using an enhanced chemiluminiscence kit as indicated by the manufacturer (Pierce). 
Statistical analysis
Data are presented as mean + SEM. Significance was determined using the Student's t test. Differences were considered significant at p < 0.05.
Results
Sol-Eng attenuates MAPK signaling activity and inhibits cell proliferation of spindle carcinoma cells
CarC is a malignant spindle cell line derived from a mouse skin carcinoma 1C ). As CarC secretes autocrine growth factors, we also studied the growth properties of the transfectants in the absence of serum. In this case, reduced growth of CSE1 and CSE3 vs mock cells was more evident (Fig. 1D ). It can be argued that Sol-Eng while being synthesized inside CSE cells could interfere with the cell cycle machinery slowing down proliferation. In order to address this possibility, we incubated cells with a purified recombinant human Sol-Eng (rhSol-Eng) protein and found that it efficiently inhibited both mock and CSE cell growth (Fig. 1E) .
A slight reduction of cell growth was also observed in vivo after injection of CarC cell transfectants into athymic nude mice. Tumors induced by CSE3 (and also CSE1 at the first two weeks post-injection) grew slower than those induced by mock cells (Fig. 2A) . The basis for the different tumorigenic behavior of CSE1 and CSE3 is presently unknown since both clones express similar levels of Sol-Eng in vitro (Fig. 1A,   B ) and in vivo ( (Fig. 2D ), whereas no variation was observed in the total ERK1/2 expression levels. In vitro, this reduction was more pronounced in CSE3 (Fig.   2C ), which may account for the slightly weaker tumorigenic potential of CSE3 with respect to CSE1 ( Fig. 2A) .
Sol-Eng blocks TGF-1-induced cell growth
In contrast to normal keratinocytes and SCC cells, spindle carcinoma cells are not only insensitive to the TGF-1 growth inhibitory response, but their growth is stimulated by the cytokine (32) . Accordingly, proliferation of mock cells was slightly increased by TGF-1 in a dose-dependent manner (Fig. 3A) . In contrast, this TGF-1-dependent growth stimulation did not occur in CSE3 cells. Moreover, TGF-1 at 1 ng/ml was able to activate the ERK1/2 pathway in mock but not in CSE3 cells ( Fig. 2A and C) . In addition, HGFdependent activation of Met and its downstream effector ERK1/2 were blocked in both CSE1 and CSE3 cells that express/secrete Sol-Eng (Fig. 5B, C) . In mock cells, HGF induced the downregulation of Met shortly after stimulation for 5-10 min (Fig. 5B, C) .
Interestingly, baseline Met levels in CSE1 and CSE3 were also reduced with respect to mock cells (Fig. 5A-C (Fig. 5D ). We next studied whether full-length human endoglin (Eng) was able to inhibit HGF stimulation of Met signaling. As shown in Figure 5E , Eng stably expressed at the plasma membrane of CarC cells (22) was unable to inhibit HGF-induced phosphorylation of both Met and ERK1/2. Also, Met protein levels were not affected by expression of full-length endoglin, but were down-regulated upon stimulation with HGF, as expected (Fig. 5E ).
In order to ascertain whether Sol-Eng interacts with Met, we performed coimmunoprecipitation analysis. To this end, HEK-293T cells were cotransfected with constructs encoding Sol-Eng tagged with HA and untagged Met. Immunoprecipitation with anti-Met antibody clearly coprecipitated HA-Sol-Eng (Fig. 5F , upper panel), whereas a weaker coprecipitation signal of Met with anti-HA-Sol-Eng was detected (Fig. 5F, lower panel) . We also cotransfected constructs encoding Met and either SolEng or full-length Eng, both tagged with HA, in HEK-293T cells. Interestingly, Met immunoprecipitation coprecipitated both full-length and truncated soluble endoglin proteins (Fig. 5G) .
Sol-Eng impairs migration/invasion of spindle carcinoma cells
CarC cells are highly migratory and invasive in vitro and in vivo (35, 36) . Using
Transwell migration assays, in which the filter was coated (invasion) or not (migration) with Matrigel, HGF was able to stimulate further CarC cell migration and invasion by ~1.5 and ~4 folds, respectively, (Fig. 6A, B) . In order to test whether Sol-Eng and fulllength Eng had some effect on this behavior, we compared the migratory/invasive abilities of CSE3 and CarC-Eng with that of the parental and control cells before and after HGF stimulation. Compared to mock cells, CSE3 showed strongly decreased basal migratory and invasive abilities and were refractory to HGF stimulation (Fig. 6C, D) . In contrast, CarC-Eng cells exhibited a substantial reduction in their migratory capacities under basal conditions, and showed only a slight, but non-significant, decreased invasiveness (Fig. 6A, B) . Fig. 2A) . This could be due to the undetermined actions of Sol-Eng on stromal cells that might compensate the direct growth inhibitory effect exerted by this molecule on tumor cells. In this regard, it is also worth emphasizing the active crosstalk between stromal and tumor cells by which stromal-dependent epithelial endoglin shedding constitutes a mechanism that may exert an environmental control of cell malignancy (38) . We also show that Sol-Eng counteracts the mild stimulation of CarC cell proliferation as well as the further activation of MAPK signaling induced by TGF-1. The mechanism for this blockade is uncertain since although it has been reported that Sol-Eng acts as a scavenger for TGF-1 preventing its binding to the cell surface receptors (14) , this has been questioned by other laboratories (16, 17) . Notwithstanding, the most striking observation of the present report is the inhibitory effect exerted by Sol- Intriguingly, full-length endoglin while coimmunoprecipitating with Met ( Fig. 5G ) was unable to downmodulate it and prevent its signaling activity.
Spindle carcinoma cell lines exhibit a high ratio of active phosho-Met respect to total Met protein levels compared with cell lines corresponding to earlier stages of tumor progression (Fig. 4F ). This is due to the fact that spindle carcinoma cells tend to express higher levels of HGF. Indeed, elevated expression of HGF appears to be a hallmark of malignant progression during mouse skin carcinogenesis in vivo, since HGF levels increase during progression from papillomas to SCCs and are further enhanced in SpCCs (Fig. 4B) . High levels of HGF in the serum of breast cancer patients correlate with shorter disease-free survival and increased metastasis in lymph nodes (39, 40) . In this respect, skin spindle cell carcinomas (represented by the CarC cell line) resemble claudin-low, basal-type breast carcinomas (41) , where Met activation is associated with high aggressiveness and poor patient outcome (42, 43) .
In summary, our results suggest that Sol-Eng antagonizes Met signaling activity at advanced stages of carcinogenesis. These data together with the anti-angiogenic action ascribed to Sol-Eng (12, 14, 17) Immunopreciptates were subjected to SDS-PAGE electrophoresis and immunoblotted with anti-HA mAb. The presence of Met in the precipitate was determined with antiMet Ab. 
